FDA Inspection
AbbVie Inc.AbbVie Inc. – FDA Inspection, Aug 6, 2015
Record Details
This FDA Inspection record concerns AbbVie Inc., with an inspection on August 6, 2015, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- AbbVie Inc.
- Inspection Date
- August 6, 2015
- Product Type
- Drugs
View Company Profile
ID · e003e4e6-9bd9-484a-8dd1-baa468c97ea6
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 934438
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.198(a)Procedures to be written and followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of AbbVie Inc.
9| Date | Classification | Office | Project area |
|---|---|---|---|
| March 3, 2026 | NAI | Drug Quality Assurance | |
| June 18, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 24, 2018 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| March 1, 2013 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| December 22, 2011 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for AbbVie Inc.
- FDA Inspection 1306856 - 2026-03-03
- FDA Inspection 1243191 - 2024-06-18
- FDA Inspection 1070526 - 2018-08-24
- FDA Inspection 820023 - 2013-03-01
- FDA Inspection 759271 - 2011-12-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.